Leukemia: Clinical Trials

3 trials for Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 suspended. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Suspended 3

Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+
Compound realgar natural indigo Tablet, placebo - Chronic Myelogenous Leukemia
Phase 3SuspendedJunmin Li6802012-11-012018-04-25
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Liposomal cytarabine, Intrathecal triple - Acute Lymphoblastic Leukemia
Phase 3SuspendedNordic Society for Pediatric Hematology and Oncology1002009-01-012012-10-10

Narrower conditions

Anemia, Aplastic (1)  ·  Bone Marrow Failure Disorders (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Mucositis (1)  ·  Neoplasms (1)  ·  Neurotoxicity Syndromes (1)  ·  Pain, Intractable (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Bone Marrow Diseases (2)  ·  Neoplasms (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Anemia (1)  ·  Chemically-Induced Disorders (1)  ·  Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)

Interventions

Cytarabine (1)  ·  Hydromorphone (1)  ·  Methadone (1)  ·  Methylprednisolone (1)  ·  Morphine (1)  ·  Passive Cutaneous Anaphylaxis (1)  ·  Prednisolone (1)

Sponsors

Junmin Li (1)  ·  Nordic Society for Pediatric Hematology and Oncology (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

China (1)  ·  Denmark (1)  ·  Finland (1)  ·  Iceland (1)  ·  Norway (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Arja Harila-Saari, MD (1)  ·  Saijuan Chen, M.D. (1)  ·  Victor M Aquino, MD (1)